Home> Products> debilitating condition

{ "products": [ { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2025-12-11T07:34:33.738Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ab3c3ca84cd189c25c409", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIDORIGHT 10 ", "description": "MIDORIGHT 10 \nMidodrine Hydrochloride 10 mg\nIntroduction:\n\nMIDORIGHT 10 contains Midodrine Hydrochloride (10 mg), a powerful medication used to treat orthostatic hypotension, a condition where blood pressure drops significantly upon standing. Midodrine works by constricting blood vessels, which increases blood pressure and alleviates symptoms such as dizziness and lightheadedness.\nKey Features and Benefits:\n\nBlood Pressure Regulation: Midodrine Hydrochloride effectively increases blood pressure by causing vasoconstriction, thereby reducing symptoms of orthostatic hypotension.\nSymptom Relief: By stabilizing blood pressure, MIDORIGHT 10 helps alleviate common symptoms of orthostatic hypotension, including dizziness, lightheadedness, and fainting.\nImproved Quality of Life: Patients using Midodrine often experience an improved ability to perform daily activities without the debilitating effects of low blood pressure.\nRapid Action: Midodrine is fast-acting, providing quick relief from symptoms of orthostatic hypotension.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIDORIGHT 10 is 10 mg taken three times a day. The dosing schedule should be closely followed to maintain consistent blood pressure levels throughout the day.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment. The usual maintenance dose is 10 mg taken three times daily.\nAdministration: The tablet should be taken orally with water, ideally during the daytime and not within four hours before bedtime to avoid supine hypertension (high blood pressure while lying down).\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/midoright-10-134242", "price": 1100.0, "discountamount": 330.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "Life", "Order", "EMAIL", "water", "tablet", "bedtime", "ability", "product", "Benefits", "fainting", "Patients", "response", "standing", "treatment", "condition", "dizziness", "MIDORIGHT", "four hours", "information", "quick relief", "Key Features", "sterispharma", "sterisonline", "Introduction", "Rapid Action", "blood vessels", "CALL/WHATSAPP", "Administration", "Initial Dosage", "Symptom Relief", "lightheadedness", "common symptoms", "dosing schedule", "Improved Quality", "daily activities", "vasoconstriction", "low blood pressure", "Maintenance Dosage", "high blood pressure", "supine hypertension", "powerful medication", "healthcare provider", "debilitating effects", "typical starting dose", "usual maintenance dose", "Midodrine Hydrochloride", "orthostatic hypotension", "Blood Pressure Regulation", "consistent blood pressure levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1853, "imageuri": "https://productimages.withfloats.com/actual/666ab3c6492d7ea0aba01e26.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ab3c6492d7ea0aba01e26.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:54:27.938Z", "updatedon": "2024-06-26T10:58:16.194Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/midoright-10-/1853", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIDORIGHT 10 ", "category": "NEUROLOGYRANGE", "tags": [ "midodrine mechanism of action", "midodrine 10 mg", "midodrine dosage", "midodrine daily dose", "midodrine classification", "midodrine patient teaching" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ab2ab70774b1f84f68deb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIDORIGHT 5 ", "description": "MIDORIGHT 5 \nMidodrine Hydrochloride 5 mg\nIntroduction:\n\nMIDORIGHT 5 contains Midodrine Hydrochloride (5 mg), a medication primarily used to treat orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing. Midodrine works by constricting blood vessels, which increases blood pressure and alleviates symptoms such as dizziness and lightheadedness.\nKey Features and Benefits:\n\nBlood Pressure Regulation: Midodrine Hydrochloride effectively increases blood pressure by causing vasoconstriction, thereby reducing symptoms of orthostatic hypotension.\nSymptom Relief: By stabilizing blood pressure, MIDORIGHT 5 helps alleviate common symptoms of orthostatic hypotension, including dizziness, lightheadedness, and fainting.\nImproved Quality of Life: Patients using Midodrine often experience an improved ability to perform daily activities without the debilitating effects of low blood pressure.\nRapid Action: Midodrine is fast-acting, providing quick relief from symptoms of orthostatic hypotension.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIDORIGHT 5 is 5 mg taken three times a day. The dosing schedule should be closely followed to maintain consistent blood pressure levels throughout the day.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 5 mg to 10 mg taken three times daily.\nAdministration: The tablet should be taken orally with water, ideally during the daytime and not within four hours before bedtime to avoid supine hypertension (high blood pressure while lying down).\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/midoright-5-134225", "price": 750.0, "discountamount": 225.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "Life", "EMAIL", "water", "Order", "tablet", "bedtime", "ability", "standing", "Benefits", "fainting", "Patients", "response", "treatment", "dizziness", "condition", "MIDORIGHT", "medication", "four hours", "information", "sterispharma", "Introduction", "sterisonline", "Key Features", "Rapid Action", "quick relief", "CALL/WHATSAPP", "blood vessels", "Initial Dosage", "Administration", "Symptom Relief", "dosing schedule", "common symptoms", "lightheadedness", "vasoconstriction", "daily activities", "Improved Quality", "significant drop", "Maintenance Dosage", "low blood pressure", "healthcare provider", "supine hypertension", "high blood pressure", "debilitating effects", "typical starting dose", "usual maintenance dose", "Midodrine Hydrochloride", "orthostatic hypotension", "Blood Pressure Regulation", "consistent blood pressure levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1852, "imageuri": "https://productimages.withfloats.com/actual/666ab2acae2cbfae74d16fe3.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ab2acae2cbfae74d16fe3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:49:47.339Z", "updatedon": "2024-06-26T10:57:21.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/midoright-5-/1852", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIDORIGHT 5 ", "category": "NEUROLOGYRANGE", "tags": [ "midodrine 5 mg price", "Midodrine Hydrochloride 5 mg", "", "MIDORIGHT 5", "", "midodrine 5 mg uses", "midodrine mechanism of action" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666aab599b27ca0f04a6c40c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIDORIGHT 2.5", "description": "MIDORIGHT 2.5\nMidodrine Hydrochloride (2.5mg)\nIntroduction:\n\nMIDORIGHT 2.5 contains Midodrine Hydrochloride (2.5 mg), a medication primarily used to treat orthostatic hypotension (a condition where blood pressure drops significantly upon standing). Midodrine works by constricting blood vessels, which increases blood pressure and improves symptoms such as dizziness and lightheadedness.\nKey Features and Benefits:\n\nBlood Pressure Regulation: Midodrine Hydrochloride effectively increases blood pressure by causing vasoconstriction, thereby reducing symptoms of orthostatic hypotension.\nSymptom Relief: By stabilizing blood pressure, MIDORIGHT 2.5 helps alleviate common symptoms of orthostatic hypotension, including dizziness, lightheadedness, and fainting.\nImproved Quality of Life: Patients using Midodrine often experience an improved ability to perform daily activities without the debilitating effects of low blood pressure.\nRapid Action: Midodrine is fast-acting, providing quick relief from symptoms of orthostatic hypotension.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of MIDORIGHT 2.5 is 2.5 mg taken three times a day. The dosing schedule should be closely followed to maintain consistent blood pressure levels throughout the day.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 2.5 mg to 10 mg taken three times daily.\nAdministration: The tablet should be taken orally with water, ideally during the daytime and not within four hours before bedtime to avoid supine hypertension (high blood pressure while lying down).\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/midoright-2-5-134227", "price": 695.0, "discountamount": 208.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "Life", "Order", "EMAIL", "water", "tablet", "ability", "bedtime", "product", "response", "Patients", "fainting", "Benefits", "standing", "treatment", "dizziness", "condition", "four hours", "medication", "information", "sterisonline", "sterispharma", "Introduction", "Key Features", "Rapid Action", "quick relief", "CALL/WHATSAPP", "blood vessels", "MIDORIGHT 2.5", "Administration", "Initial Dosage", "Symptom Relief", "common symptoms", "dosing schedule", "lightheadedness", "daily activities", "Improved Quality", "vasoconstriction", "low blood pressure", "Maintenance Dosage", "high blood pressure", "supine hypertension", "healthcare provider", "debilitating effects", "typical starting dose", "usual maintenance dose", "Midodrine Hydrochloride", "orthostatic hypotension", "Blood Pressure Regulation", "consistent blood pressure levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1851, "imageuri": "https://productimages.withfloats.com/actual/666aab5c844f260024689a57.png", "tileimageuri": "https://productimages.withfloats.com/tile/666aab5c844f260024689a57.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T08:18:33.527Z", "updatedon": "2024-06-26T10:56:31.715Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/midoright-2-5/1851", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIDORIGHT 2.5", "category": "NEUROLOGYRANGE", "tags": [ "midodrine hydrochloride tablets (tablet) 2.5mg", "midodrine 2.5 tablet", "midodrine hydrochloride tablets usp 2.5 mg uses", "midodrine side effects weight gain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694004d8504825bb23fa3c1f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Terbinafine and Itraconazole Tablets 250/100 mg", "description": "CONARIS T100 is a potent antifungal medication formulated with Terbinafine 250 mg and Itraconazole 100 mg. This combination tablet is designed to treat a wide range of fungal infections affecting the skin, nails, and other body parts. Terbinafine and Itraconazole work synergistically to eliminate fungi effectively by targeting their cell membranes and inhibiting growth, providing faster relief from symptoms such as itching, redness, scaling, and discomfort.\n\nFungal infections are common in humid climates and among individuals with compromised immunity, and medications like CONARIS T100 are essential for managing stubborn and recurrent infections. This combination therapy is often prescribed by dermatologists and healthcare professionals for moderate to severe fungal conditions.\n\nUses\n\nCONARIS T100 is used in the treatment of several fungal infections, including:\n\nDermatophytosis (Ringworm): Effective against infections of the skin, hair, and nails caused by dermatophytes.\n\nOnychomycosis (Nail Fungus): Helps in treating fungal infections of fingernails and toenails.\n\nTinea Infections: Treats tinea corporis, tinea cruris, and tinea pedis (athlete’s foot).\n\nCandidiasis: Useful in managing Candida infections affecting the skin and mucous membranes.\n\nRecurrent or Resistant Fungal Infections: Provides stronger antifungal action in cases not responsive to monotherapy.\n\nBenefits\n1. Broad-Spectrum Antifungal Action\n\nThe combination of Terbinafine and Itraconazole ensures effective activity against a wide variety of fungal species, including dermatophytes and yeasts.\n\n2. Faster Symptom Relief\n\nBy targeting fungi at multiple levels, CONARIS T100 helps relieve itching, redness, scaling, and discomfort more quickly than single-agent therapy.\n\n3. Treats Nail and Skin Infections\n\nTerbinafine penetrates nails effectively, while Itraconazole enhances the antifungal spectrum, making the combination ideal for nail and skin fungal infections.\n\n4. Reduces Recurrence\n\nCombination therapy decreases the risk of fungal infections returning by ensuring complete eradication of the pathogen.\n\n5. Convenient Dosage Form\n\nAvailable as an oral tablet, making it easy to administer and suitable for long-term treatment if prescribed.\n\nDosage\n\nAdults: Usually, one tablet of CONARIS T100 daily, preferably after meals, or as directed by a healthcare professional.\n\nTreatment Duration: Varies depending on the type and severity of infection; may range from 2 to 12 weeks for skin infections and longer for nail infections.\n\nImportant: Do not self-adjust dosage or stop treatment prematurely, as incomplete therapy can lead to recurrence or resistance.\n\nSide Effects\n\nCONARIS T100 is generally well tolerated when used as prescribed. Mild side effects may include:\n\nNausea or vomiting\n\nStomach upset or diarrhea\n\nHeadache\n\nDizziness\n\nSerious Side Effects (Rare)\n\nLiver enzyme elevation (monitoring recommended for long-term use)\n\nAllergic reactions such as rash, itching, or swelling\n\nSevere gastrointestinal discomfort\n\nConsult a healthcare provider immediately if you experience jaundice, persistent fatigue, or severe allergic reactions.\n\nPrecautions and Warning\n\nPregnancy and Breastfeeding: Use only if prescribed by a doctor; safety during pregnancy is not fully established.\n\nLiver or Kidney Disorders: Dose adjustment or close monitoring may be required.\n\nDrug Interactions: Inform your doctor about all medications, especially antifungals, statins, or anticoagulants.\n\nAvoid Self-Medication: Fungal infections may mimic other skin conditions, so proper diagnosis is essential.\n\nAlcohol Consumption: Avoid alcohol as it may increase liver toxicity risk.\n\nStorage: Store in a cool, dry place away from direct sunlight and out of children’s reach.\n\nConclusion\n\nCONARIS T100, containing Terbinafine 250 mg and Itraconazole 100 mg, is a reliable and effective treatment for a wide spectrum of fungal infections, including skin, nail, and mucosal infections. Its dual-action antifungal mechanism provides faster symptom relief, reduces recurrence, and improves overall patient outcomes.\n\nWhen used under medical supervision and following prescribed dosage, CONARIS T100 offers a safe and convenient option for managing both common and stubborn fungal infections, ensuring better skin and nail health and enhanced quality of life.", "price": 184.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2248, "imageuri": "https://productimages.withfloats.com/actual/694004da351fe1d6b98476e6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694004da351fe1d6b98476e6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-15T12:53:44.573Z", "updatedon": "2025-12-16T05:44:32.639Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/terbinafine-and-itraconazole-tablets-250-100-mg/2248", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CONARIS T100", "category": "DERMATALOGY", "tags": [ "terbinafine and itraconazole tablets", "terbinafine and itraconazole together", "terbinafine and itraconazole tablets uses", "terbinafine and itraconazole for nail fungus" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "693c05831844c6739ab3e83a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mefenamic Acid and Paracetamol Suspension", "description": "METAPECT MF KID SUSPENSION stands out as a specialized formulation from Steris Healthcare Pvt Ltd, blending Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), with Paracetamol, a widely used analgesic and antipyretic. Typically available in a 60ml bottle with child-friendly flavoring, it contains precise concentrations like 100mg Mefenamic Acid and 250mg Paracetamol per 5ml serving, ensuring accurate dosing via the included measuring cup. This sugar-free or low-sugar variant minimizes dental risks while providing rapid absorption for faster onset compared to solid forms. Manufactured under stringent quality controls, it supports pediatric care by addressing inflammation at its source through COX enzyme inhibition, which curbs prostaglandin production responsible for pain signals and fever response.​\n\nThe suspension's dual-action mechanism sets it apart: Paracetamol targets the brain's hypothalamus to regulate body temperature and elevate pain thresholds, while Mefenamic Acid reduces tissue swelling and inflammatory mediators. This synergy makes METAPECT MF KID SUSPENSION more effective than single-ingredient options for multifaceted symptoms. Healthcare professionals often recommend it for short-term use in infants over six months and children, always under medical guidance to match age and weight-based dosages.​\n\nKey Uses\nMETAPECT MF KID SUSPENSION excels in managing fever associated with viral infections, teething, or post-vaccination reactions. It swiftly lowers elevated temperatures, promoting comfort and better sleep for restless kids.​\n\nFor pain relief, it tackles mild to moderate discomfort from headaches, toothaches, earaches, and sore throats common during colds or flu. Caregivers report noticeable easing of symptoms within 30-60 minutes, allowing children to resume play or eat without distress.​\n\nAdditionally, it soothes body aches, muscle strains from minor injuries, or joint pains in growing kids. In cases of post-surgical recovery or inflammatory episodes, it provides reliable support without the need for stronger opioids.​\n\nMajor Benefits\nThe primary benefit lies in its comprehensive symptom control, combining antipyretic, analgesic, and anti-inflammatory effects for holistic relief. Children experience reduced fever, less pain, and diminished swelling, leading to improved appetite and activity levels.​\n\nIts liquid suspension format ensures easy administration—no choking risks—and precise dosing prevents under- or overdosing. Flavored options like mango enhance compliance, turning medicine time into a less daunting routine for picky eaters.​\n\nCompared to alternatives, METAPECT MF KID SUSPENSION offers quicker bioavailability due to its oral liquid state, ideal for emergencies like high fever spikes at night. Long-term, it supports faster recovery by minimizing inflammation, potentially shortening illness duration when used as directed.​\n\nBenefit\tDescription:\tAdvantage over Single Agents\nFever Reduction\tLowers temperature via hypothalamic action ​\tFaster than Paracetamol alone\nPain Relief\tBlocks pain signals and prostaglandins. ​\tSuperior for inflammatory pain\nAnti-Inflammatory\tReduces swelling in tissues ​\tAddresses root cause, not just symptoms\nEasy Dosing\tLiquid with dropper for accuracy ​\tChild-friendly, no splitting tablets\nPotential Side Effects\nWhile generally well-tolerated, METAPECT MF KID SUSPENSION may cause mild gastrointestinal issues like nausea, vomiting, stomach pain, or indigestion in some children, especially if taken on an empty stomach. Administering with food can mitigate this.​\n\nLess common effects include drowsiness, dizziness, or allergic reactions such as rashes, itching, or swelling—seek immediate medical help if these occur. Prolonged use risks liver strain from Paracetamol or kidney concerns from Mefenamic Acid, so adhere strictly to prescribed durations.​\nRarely, it might lead to diarrhea, headache, or elevated liver enzymes. Monitoring is key; consult a doctor for persistent symptoms or in kids with pre-existing conditions like asthma or ulcers.​\n\nDosage Guidelines\nFollow pediatrician-recommended doses based on weight: typically 5-10ml every 6-8 hours, not exceeding 4 doses daily. Shake well before use and store below 30°C away from light.​\nAvoid in neonates under 6 months or those with hypersensitivity. Hydration and diet play roles in efficacy—pair with plenty of fluids.​\nConclusion\nMETAPECT MF KID SUSPENSION empowers parents with a dependable tool for childhood pain and fever, blending efficacy, safety, and convenience under Steris Healthcare's trusted banner. Quick relief restores normalcy, but professional oversight ensures optimal outcomes.", "price": 57.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2241, "imageuri": "https://productimages.withfloats.com/actual/693c05860443b6722a4db029.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c05860443b6722a4db029.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:07:31.874Z", "updatedon": "2025-12-12T12:07:31.874Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mefenamic-acid-and-paracetamol-suspension/2241", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT MF KID SUSPENSION", "category": "PEDIATRICS", "tags": [ "Mefenamic Acid and Paracetamol Suspension", "Paracetamol", "Mefenamic Acid and 250mg Paracetamol per 5ml serving", "COX enzyme inhibition", "pain and fever", "Pain Relief" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937d6192800555f6696845e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Naltrexone Hydrochloride IP 50 mg", "description": "Naltrexone Hydrochloride IP 50 mg, marketed under the brand name NALTREXON 50, is a prescription medication primarily used in the management of opioid and alcohol dependence. This potent pharmaceutical agent plays a crucial role in addiction treatment programs by helping individuals reduce or eliminate their reliance on addictive substances. Below is an in-depth description of the product, its uses, key benefits, possible side effects, and a concluding overview.\n\nProduct Description\nNALTREXON 50 contains Naltrexone Hydrochloride as its active ingredient, formulated as an immediate-release tablet with a strength of 50 mg per tablet. Naltrexone is an opioid antagonist, meaning it works by blocking the opioid receptors in the brain. By binding to these receptors without activating them, Naltrexone prevents opioids from producing their euphoric and sedative effects, which are often responsible for addiction.\nPharmacologically, Naltrexone Hydrochloride belongs to the class of medications known as opioid antagonists, specifically targeting mu, kappa, and delta opioid receptors. Its chemical composition and formulation comply with the Indian Pharmacopoeia (IP) standards, ensuring high quality and purity that meet regulatory guidelines.\n\nNALTREXON 50 is indicated for adults who are already detoxified from opioids or alcohol and are motivated to maintain abstinence from these substances. It supports addiction recovery by reducing cravings and diminishing the rewarding effects if relapse occurs.\n\nUses of NALTREXONE 50\nNALTREXONE 50 is primarily prescribed for two major therapeutic purposes:\n\nAlcohol dependence management: It helps reduce the desire to consume alcohol and lowers the risk of relapse by blocking alcohol’s rewarding effects in the brain.\n\nOpioid dependence treatment: Naltrexone aids in preventing relapse by blocking the euphoric and sedative effects induced by opioid drugs like heroin, morphine, and prescription painkillers.\n\nThe medication is typically administered as part of a comprehensive addiction treatment plan that includes counseling, behavioral therapies, and support groups. It is essential that the patient is opioid-free for at least 7 to 10 days before starting Naltrexone to avoid precipitating withdrawal symptoms.\n\nKey Benefits\nReduces cravings and relapse: By blocking opioid receptors, NALTREXON 50 reduces cravings and diminishes the pleasure derived from alcohol or opioid consumption, which helps patients stay abstinent.\n\nNon-addictive: Unlike some addiction treatments that contain opioids, Naltrexone is non-addictive and does not produce tolerance or dependence.\n\nSupports long-term recovery: When combined with behavioral therapy, Naltrexone enhances the likelihood of successful long-term abstinence from alcohol and opioids.\n\nImproves quality of life: Patients taking NALTREXONE 50 often experience improved emotional stability, better social functioning, and enhanced physical health compared to ongoing substance use.\n\nOral administration: As an oral tablet, Naltrexone is easy to administer, improving patient compliance.\n\nReduces overdose risk: By blocking the euphoric effects of opioids, it reduces the temptation to use high doses, thereby decreasing the risk of overdose.\n\nSide Effects\nLike all medications, NALTREXON 50 can cause side effects, although not everyone experiences them. Common side effects associated with Naltrexone Hydrochloride include:\n\nNausea and vomiting: These digestive issues are most frequent during the initial treatment phase but often subside with continued use.\n\nHeadache: Mild to moderate headaches may occur.\n\nDizziness and fatigue: Some patients report feeling dizzy or tired, particularly in the beginning.\n\nInsomnia: Difficulty sleeping or altered sleep patterns may be experienced.\n\nAnxiety or nervousness: Some individuals may feel anxious or agitated.\n\nJoint or muscle pain: Muscle aches and joint discomfort can occasionally occur.\n\nLiver function changes: Very rarely, Naltrexone may lead to elevations in liver enzymes; therefore, monitoring liver function tests during treatment is recommended.\n\nSevere side effects or allergic reactions are uncommon but require immediate medical attention. These include symptoms such as rash, swelling, difficulty breathing, or severe abdominal pain.\n\nIt is crucial for patients to inform their healthcare provider about any pre-existing liver conditions, prescribed or over-the-counter medications, and any history of opioid- or alcohol-related health issues before starting therapy.\n\nConclusion\nNALTREXON 50, containing Naltrexone Hydrochloride IP 50 mg, is a highly effective medication designed to aid in the treatment of alcohol and opioid dependence. Its action as an opioid antagonist helps block the pleasurable effects of these substances, reduce cravings, and diminish relapse risks. When used responsibly as part of a multidisciplinary treatment approach that incorporates counseling and behavioral therapies, NALTREXON 50 significantly enhances the chances of sustained recovery and improved quality of life.\n\nThough generally well-tolerated, users should be aware of potential side effects and consult healthcare providers regularly to ensure safety throughout the course of treatment. With careful medical oversight and patient commitment, NALTREXON 50 is a valuable tool in the fight against substance dependence, offering hope for individuals seeking freedom from addiction.", "price": 745.0, "discountamount": 223.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2240, "imageuri": "https://productimages.withfloats.com/actual/6937d61c3811575f667dea96.png", "tileimageuri": "https://productimages.withfloats.com/tile/6937d61c3811575f667dea96.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:56:09.144Z", "updatedon": "2025-12-09T07:56:09.144Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/naltrexone-hydrochloride-ip-50-mg/2240", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NALTREXON 50", "category": "NEUROLOGY RANGE", "tags": [ "Naltrexone Hydrochloride IP 50 mg", "alcohol dependence", "opioid antagonist", "Naltrexone is easy to administer", "opioid- or alcohol-related health issues", "NALTREXONE 50" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6937c92e461b07808ef722e4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cyclosporine 100mg", "description": "Cyclosporine, marketed under the brand name CYCLOPURE 100, is a potent immunosuppressant medication widely used in clinical settings to prevent organ transplant rejection and to manage various autoimmune disorders. Available as a 100mg oral capsule, CYCLOPURE 100 plays a critical role in modulating the immune system, helping patients maintain graft survival and control symptoms of immune-related diseases.\n\nProduct Description\nCYCLOPURE 100 contains cyclosporine, a cyclic polypeptide consisting of 11 amino acids, derived from the fungus Tolypocladium inflatum. It selectively inhibits the activity of T-lymphocytes, a subset of white blood cells that play a central role in immune response. By targeting these immune cells, cyclosporine helps prevent the body’s immune system from attacking transplanted organs, such as kidneys, liver, or heart, and reduces inflammation in autoimmune diseases.\n\nThe capsules are formulated for oral administration, with each capsule containing 100mg of cyclosporine. This dosage provides an effective balance between immunosuppression and safety for most adult patients, although dosing must be carefully tailored by healthcare providers based on patient response, therapeutic drug monitoring, and condition severity.\n\nUses of CYCLOPURE 100\nCYCLOPURE 100 is primarily indicated for the following medical purposes:\n\nPrevention of Organ Transplant Rejection: It is commonly prescribed to recipients of kidney, liver, heart, or other organ transplants to prevent acute and chronic rejection by suppressing immune responses that target the graft.\n\nAutoimmune Disease Management: Cyclosporine is effective in treating autoimmune disorders such as rheumatoid arthritis, psoriasis, and certain types of nephrotic syndrome. By reducing immune system overactivity, it helps alleviate symptoms such as joint inflammation, skin lesions, and kidney damage.\n\nSevere Atopic Dermatitis: In cases where conventional treatments are ineffective, cyclosporine may be used to control symptoms of severe eczema by modulating immune hyper-reactivity.\n\nOther Off-Label Uses: Occasionally, cyclosporine is used for other immune-mediated conditions like uveitis, Crohn’s disease, and some forms of lupus nephritis depending on physician discretion.\n\nKey Benefits\nEffective Immunosuppression: CYCLOPURE 100 is known for its potent ability to suppress immune responses selectively, significantly reducing the risk of organ rejection after transplantation and improving graft survival rates.\n\nVersatility in Autoimmune Conditions: Beyond organ transplantation, cyclosporine’s immunomodulatory effects provide relief in autoimmune diseases by controlling inflammation and immune overactivity that cause tissue damage.\n\nImprovement in Quality of Life: By controlling disease symptoms such as joint pain, skin inflammation, or kidney impairment, CYCLOPURE 100 enables patients to experience improved physical comfort and daily functioning.\n\nOral Administration Convenience: The capsule form ensures ease of use and better patient compliance compared to injectable immunosuppressants, allowing therapy to be managed on an outpatient basis.\n\nTherapeutic Drug Monitoring: The availability of blood level monitoring helps customize dosage and maximize therapeutic effects while minimizing toxicity.\n\nSide Effects and Precautions\nWhile CYCLOPURE 100 is highly beneficial, it carries a risk of side effects due to its immunosuppressive nature and systemic effects. Common, less severe side effects include:\n\nGingival hyperplasia (gum overgrowth)\n\nTremors or mild neurological symptoms\n\nHypertension (high blood pressure)\n\nIncreased hair growth (hypertrichosis)\n\nGastrointestinal disturbances (nausea, diarrhea)\n\nMore serious adverse effects, which require immediate medical attention, can include:\n\nNephrotoxicity: Cyclosporine can affect kidney function; regular monitoring of kidney function tests is essential.\n\nIncreased Risk of Infections: Suppression of the immune system increases vulnerability to bacterial, viral, and fungal infections.\n\nHepatotoxicity: Liver function should be monitored as cyclosporine may cause elevated liver enzymes or more severe liver damage.\n\nMalignancies: Long-term use has been associated with an increased risk of certain cancers, particularly lymphomas and skin cancers.\n\nElectrolyte Imbalances: Hypomagnesemia and hyperkalemia are possible and require monitoring.\n\nPatients must inform their healthcare providers about other medications they take, as cyclosporine has significant drug interactions that can affect its blood levels and toxicity risk, including with antibiotics, antifungals, anticonvulsants, and others.\n\nConclusion\nCYCLOPURE 100 (Cyclosporine 100mg) stands as a cornerstone immunosuppressant medication that plays a vital role in preventing organ rejection and managing autoimmune diseases. Its targeted immunosuppressive action effectively reduces disease burden, enhances graft survival, and improves patients’ quality of life. Although it entails risks of side effects, careful medical supervision, therapeutic drug monitoring, and adherence to prescribed dosing protocols effectively mitigate these concerns.\n\nFor patients undergoing organ transplantation or those with autoimmune conditions unresponsive to standard therapies, CYCLOPURE 100 provides a valuable therapeutic solution. Always consult a healthcare professional before starting or adjusting therapy with CYCLOPURE 100 to ensure the safest and most effective use tailored to individual clinical needs.", "price": 1014.0, "discountamount": 305.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2239, "imageuri": "https://productimages.withfloats.com/actual/6937c930ed26b2c06ce34f7e.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/6937c930ed26b2c06ce34f7e.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-09T07:01:02.399Z", "updatedon": "2025-12-09T07:01:02.399Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cyclosporine-100mg/2239", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CYCLOPURE 100", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }